Possible drug target for obesity treatment a no-brainer: study

February 4, 2009

Scientists at the University of North Carolina at Chapel Hill School of Medicine have discovered a gene that when mutated causes obesity by dampening the body's ability to burn energy while leaving appetite unaffected.

The new research could potentially lead to new pharmacologic approaches to treating obesity in humans that do not target the brain, according to study senior author Yi Zhang, Ph.D., Howard Hughes Medical Institute investigator and professor of biochemistry and biophysics in the UNC School of Medicine. Zhang is also a member of the UNC Lineberger Comprehensive Cancer Center.

The findings also add new knowledge to the burgeoning field of epigenetics, in which heritable changes in gene expression or physical appearance are caused by mechanisms besides changes in the underlying DNA.

The gene in question encodes for a specific epigenetic factor, an enzyme called Jhdm2a. In 2006, Zhang showed that Jhdm2a was able to demethylate, or remove, a methyl group from one of four histone proteins bound to all genes. Because they are so intimately associated with DNA, even slight chemical alterations of histones can have profound effects on nearby genes.

The new study focused on a line of so-called "knockout" mice that lacked the Jhdm2a gene. Zhang found impairment in two molecular signaling pathways important for normal function in brown fat tissue and muscle cells. Both pathways exert a major influence on metabolism, the body's conversion of food to energy. Without the enzyme, the mice had reduced metabolisms, becoming visibly obese.

To Zhang's knowledge, this is the first mouse model to exhibit obese traits that do not resulting from an alteration in appetite, which is largely a brain function. "Given that this gene is not expressed in the brain, any drug that targets this gene would not have an effect on brain function," he said. "Therefore, we are really looking for a pure effect on metabolism."

With that in mind, Zhang anticipates that the study, published online February 4, 2009 in the journal Nature, could be of great interest to pharmaceutical companies eager to develop new anti-obesity drugs aimed at a novel, new molecular target expressed in non-brain tissues.

Zhang said his group will continue to look for more detailed mechanisms involved in how the enzyme regulates the relevant genes and changes in the metabolic rate.

"My lab has a long-term interest in identifying histone-modifying enzymes," said Zhang. "Three years ago, we discovered the jumanji family of histone demethylase, which is a huge family and brought big interest in the field to study this group of genes."

That body of work has contributed significantly to a new understanding that mutations in epigenetic factors such as histone demethylase enzymes can have profound physiologic effects. The team had already zeroed in on the Jhdm2a enzyme, showing in a 2007 Nature publication that the Jhdm2a gene is highly expressed in mouse testes and plays an important role in spermiogenesis, the final step in the production of a functional sperm cell. Male mice with the gene knocked out were infertile.

That discovery has provided researchers with a new potential cause for male infertility, just as the current study shows that the same genetic defect leads to obesity in both male and female animals, shedding new light on the role of epigenetics in regulating metabolism.

"So this gene has at least two biological functions," Zhang said. "One is control of spermiogenesis; the other is control of metabolism."

This finding was not necessarily expected by the researchers. "Nobody could have predicted that this gene had this particular function in regulating metabolism," Zhang said. "The histone-modifying enzymes actually have broad effect - every gene is packaged by histones. Therefore, when modifying histones, you can't necessarily predict what function will be affected."

In addition to being obese, the Jhdm2a knockout mouse also developed other characteristics related to human metabolic disorder, such as hyperlipidemia (raised lipid levels) and insulin resistance. Whether the mouse results will be mirrored in humans remains to be seen. "We don't know whether this gene is defective in some of the obese or metabolic syndrome patients - those are things that need to be investigated," Zhang said.

One of the lines of research Zhang and his colleagues will pursue is to conduct experiments with "conditional" knockout mouse models, in which the gene of interest is functionally removed from specific tissues, such as, in this case, brown fat or muscle tissue. According to Zhang, "that way we can ask specific questions and can pinpoint the specific tissue or cell types…then we can also pinpoint the specific molecular mechanism."

Source: University of North Carolina School of Medicine

Explore further: BioGPS: An online tool that allows users to building custom mashups of gene annotations and expression profiles

Related Stories

Gene drive reversibility introduces new layer of biosafety

November 16, 2015

In parallel with their development of the first synthetic gene drives - which greatly increase the chance a specific gene will be passed on to all offspring - George Church, Ph.D., and Kevin Esvelt, Ph.D., helped pioneer ...

Mysteries of bony fish genome evolution

November 16, 2015

As the 20th-century novelist Joseph Conrad famously wrote, "It's only those who do nothing that make no mistakes, I suppose," and Nature is very busy, so she makes lots of them. But as a genius, she can use them to advantage. ...

Surprising signal to control male fertility

November 20, 2015

Signaling molecules of the Wnt family are ubiquitous in biology. From cnidaria to man, they are responsible for forming the basic shape of all organisms. Without Wnt, our body would not have a top or bottom, front or rear. ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 04, 2009
Vulvox has a silencer RNA synthesis program that can lead to long term silencing of genes. Some proteins that downregulate PPAR receptors or that demethylate histones might be silenced using that technology.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.